Mental Health Across the Ages

The focus on and advancement of treatment for mental health has evolved rapidly over the past few years. Treatment for mental health conditions in pediatric and older adult populations, in particular, continue to evolve and with that progress, medication shortages have become a more common problem for clinical pharmacists to overcome in service to these patients. This session will focus on key aspects of mental health in the patient populations of pediatrics, adults, and older adults. Part one of the session will start with discussion of ADHD medication use in both pediatric and adult patients and provide attendees with updates and guidance on management of drug shortages within this area. Part two of the session will include a discussion of the new monoclonal antibodies in the treatment of Alzheimer’s Disease and those who would most benefit from this emerging therapy. The knowledge-based activity will include lectures, examples, and audience participation.

Moderator: Jeremy Daniel, Pharm.D., FAAPP, BCPP, BCPS Psychiatric Clinical Pharmacist, Avera Behavioral Health Center Associate Professor, Pharmacy Practice South Dakota State University Sioux Falls, SD   View Biography

Requiring Your Attention! Navigating ADHD Treatment Amid Rising Stimulant Use and Drug Shortages 10:30 a.m. to 11:15 a.m. Speaker: Kelly C. Lee, Pharm.D., Masters in Research, FCCP, FASHP Professor of Clinical Pharmacy University of California San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences La Jolla, California   View Biography

Monoclonal Antibody Therapy in Alzheimer’s Disease: Who, What, When, and Where 11:15 a.m. to 12:00 p.m. Speaker: Jeffrey T. Sherer, Pharm.D., MPH, BCPS Clinical Professor University of Houston College of Pharmacy Houston, Texas   View Biography